ea0014oc8.6 | Neuroendocrinology clinical | ECE2007
Skrtic Stanko
, Lennernäs Hans
, Nilsson Anna
, Bergthorsdottir Ragnhildur
, Hedner Thomas
, Johannsson Gudmundur
Background: Mortality rate in patients with primary and secondary adrenal insufficiency is increased. A contributing factor could be the dose and the pattern of glucocorticoid replacement therapy. Hydrocortisone administered twice or thrice daily produces high serum peaks and low trough values in-between. A novel, once daily, hydrocortisone modified release tablet with combined immediate and extended release characteristics was developed.Purpose: The aim...